Acadian Asset Management Portfolio holdings
AUM
$48.4B
1-Year Return
32.04%
This Quarter Return
-3.78%
1 Year Return
+32.04%
3 Year Return
+133.69%
5 Year Return
+272.69%
10 Year Return
+761.99%
AUM
$18.3B
AUM Growth
-$1.27B
(-6.5%)
Cap. Flow
-$51.9M
Cap. Flow
% of AUM
-0.28%
Top 10 Holdings %
Top 10 Hldgs %
17.81%
Holding
1,942
New
257
Increased
577
Reduced
589
Closed
267
Top Buys
| 1 |
Qiagen
QGEN
|
+$124M |
| 2 |
Check Point Software Technologies
CHKP
|
+$88.5M |
| 3 |
Murphy USA
MUSA
|
+$78M |
| 4 |
Coca-Cola Europacific Partners
CCEP
|
+$64.9M |
| 5 |
Campbell Soup
CPB
|
+$64.2M |
Top Sells
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$107M |
| 2 |
Canadian Natural Resources
CNQ
|
+$78.1M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$67.8M |
| 4 |
GSK
GSK
|
+$61M |
| 5 |
Deutsche Bank
DB
|
+$60.4M |
Sector Composition
| 1 | Technology | 24.14% |
| 2 | Healthcare | 18.35% |
| 3 | Consumer Staples | 13.67% |
| 4 | Materials | 8.84% |
| 5 | Financials | 8.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
USX
1001
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
| $477K | ﹤0.01% |
194,709
+16,986
| +10% | +$41.6K |
|
1002
Assembly Biosciences
ASMB
$171M
| $474K | ﹤0.01% |
24,146
-22,500
| -48% | -$442K |
|
1003
Artesian Resources
ARTNA
$342M
| $473K | ﹤0.01% |
+9,860
| New | +$473K |
|
1004
Weyco Group
WEYS
$285M
| $471K | ﹤0.01% |
23,276
-554
| -2% | -$11.2K |
|
1005
Cullen/Frost Bankers
CFR
$8.11B
| $470K | ﹤0.01% |
3,558
-23,375
| -87% | -$3.09M |
|
1006
argenx
ARGX
$46.7B
| $469K | ﹤0.01% |
+1,330
| New | +$469K |
|
1007
First Bank
FRBA
$415M
| $469K | ﹤0.01% |
34,390
-24,377
| -41% | -$332K |
|
1008
SmartFinancial
SMBK
$627M
| $466K | ﹤0.01% |
18,911
+6,168
| +48% | +$152K |
|
1009
BridgeBio Pharma
BBIO
$10.1B
| $465K | ﹤0.01% |
46,575
+23,130
| +99% | +$231K |
|
1010
Sysco
SYY
$38.3B
| $463K | ﹤0.01% |
6,552
-7,362
| -53% | -$520K |
|
1011
Primerica
PRI
$8.74B
| $458K | ﹤0.01% |
3,718
| – | – |
|
|
DRD
1012
DRDGold
DRD
$1.97B
| $457K | ﹤0.01% |
+84,286
| New | +$457K |
|
1013
Icahn Enterprises
IEP
$4.77B
| $455K | ﹤0.01% |
+9,174
| New | +$455K |
|
|
CALA
1014
DELISTED
Calithera Biosciences, Inc
CALA
| $455K | ﹤0.01% |
155,070
| – | – |
|
1015
4D Molecular Therapeutics
FDMT
$324M
| $454K | ﹤0.01% |
56,592
-38,367
| -40% | -$308K |
|
1016
HDFC Bank
HDB
$180B
| $452K | ﹤0.01% |
7,747
| – | – |
|
1017
Cumberland Pharmaceuticals
CPIX
$50.9M
| $451K | ﹤0.01% |
188,164
| – | – |
|
1018
Allison Transmission
ALSN
$7.41B
| $448K | ﹤0.01% |
13,279
+400
| +3% | +$13.5K |
|
1019
Hovnanian Enterprises
HOV
$869M
| $445K | ﹤0.01% |
+12,524
| New | +$445K |
|
1020
MeiraGTx Holdings
MGTX
$603M
| $445K | ﹤0.01% |
53,374
+29,507
| +124% | +$246K |
|
1021
Zscaler
ZS
$43.4B
| $443K | ﹤0.01% |
2,706
-2,889
| -52% | -$473K |
|
1022
CNB Financial Corp
CCNE
$762M
| $441K | ﹤0.01% |
18,743
| – | – |
|
1023
Pricesmart
PSMT
$3.41B
| $439K | ﹤0.01% |
7,624
| – | – |
|
1024
First American
FAF
$6.74B
| $437K | ﹤0.01% |
9,521
-128,600
| -93% | -$5.9M |
|
1025
Piper Sandler
PIPR
$5.95B
| $434K | ﹤0.01% |
4,150
-536
| -11% | -$56.1K |
|